Skip to content

The effect of topical formulation containing egg whites on healing of second degree wound in burn patients

The effect of topical formulation containing egg whites on healing of second degree wound in burn patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017053134262N1
Enrollment
90
Registered
2017-08-07
Start date
2017-06-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burn. 949

Interventions

Intervention 1: Intervention group1: Second degree ophthalmic ulcers remain intact and remain intact in the second grade wound, which are usually blisters, after removing the blisters and dead tissues
Treatment - Drugs
Intervention group1: Second degree ophthalmic ulcers remain intact and remain intact in the second grade wound, which are usually blisters, after removing the blisters and dead tissues, and after dail
Control group: The second degree otitis wounds remained completely intact and in the second grade wound, which was usually blotched, after removing the blisters and dead tissues, and after daily washi

Sponsors

Dr behzad sharif makhmal zadeh
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Second degree burns confirmed by the doctor; The age is between 18-60 years; burn percentage is less than 15 percent; It is not more than 6 hours from the time of the burn until it enters the research; Areas (face, genitals and perineum) are not included in the study due to the sensitivity of these areas; The amount of hemoglobin and total protein is in the normal range. The normal range of hemoglobin (the Ba18-14 in men and in women 16-12 grams per deciliter) and total protein (8.7 to 6.6 grams per deciliter); The patient's wound is not impregnated with contaminants; Before entering the study samples of any substance other than potable water is not used on wounds; Before entering the study, there is no sign of infection with different parts of the body; underlying immune deficiency diseases such as diabetes, cancer, AIDS, hypertension, malnutrition, etc. is not; The patient is not known to have a skin allergy; is able to respond to questions. Exclusion criteria: During the study, patients need to use immunosuppressive drugs, steroid drugs, chemotherapy drugs and radiation therapy; If there is any indication that an infected burn wounds treated. Any of these symptoms (edema in the area burned along with induration and inflammation of the edges of the wound, discoloration wound burned to dark red, brown, purple, black, presence of purulent discharge, foul-smelling, green and abundant, fever, during the course of treatment) in treated infected wounds and were removed from the sample study and treatment under doctor's supervision changes.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Burn wound. Timepoint: The first day / seven days / fifteenth day. Method of measurement: To measure wound plastic tape will be used, which is accurate to about 1: 1000 is. The admission to the clinic (first day) and during treatment seventh day and the fifteenth day, the extent of the wound by contact with a tape measure and guide the measurement of transparent measurement and the basis Length Width expressed, and Jensen wound assessment tool Bts- using parameters that are related to the extent of burn wound, the wound (ulcer depth), the edge of the wound, the destruction of underlying tissue, necrotic tissue, necrotic tissue, exudate, the exudate, color of the skin around the wound, peripheral tissue induration, edema peripheral tissues, tissue granulation and epithelialization by the researchers analyzed tissue M And according to points earned from it will be examined wound healing.

Countries

Iran (Islamic Republic of)

Contacts

Public Contacthadis ashrafizadeh

Ahvaz Jundishapur University of medical sciences, Ahvaz, Iran.

ashrafizadeh.h1993@gmail.comashrafizadeh.h@ajums.ac.irashrafizadeh.h@yahoo.com+216 133738255

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026